inhibitor

(redirected from Neuraminidase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Neuraminidase inhibitor: Oseltamivir, amantadine, Tamiflu, Zanamivir
See: deterrent
References in periodicals archive ?
In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses.
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment.
50], concentration of neuraminidase inhibitor required to reduce enzyme activity by 50%; E, passage in eggs; S, passage in MDCK-SIAT1 cells (/separates passage before and after arrival to CDC); Na, neuraminidase; NT, not tested; RT-PCR, reverse transcription pCr.
For example, the incidence of pneumonia in the placebo group was just 2%, and it was estimated that roughly 330 patients would need to be treated with a neuraminidase inhibitor to prevent one additional case of pneumonia.
In severe influenza that's not responding to recommended treatment, combination therapy with neuraminidase inhibitors, adamantanes, interferon, and ribavirin will be appropriate.
FIGURE 18 NEURAMINIDASE INHIBITOR MARKET SHARES BY REGION, 2010 (%) 87
The limited effect of oseltamivir on reducing disease duration, usually only shortening the duration by 1 day in healthy persons (4), the possibility of serious side effects (5), the possibility of the virus developing resistance to neuraminidase inhibitors (6,7), and the cost to health care of unnecessary prescriptions are reasons to strive for better adherence to prescribing guidelines.
The addition reflects postmarketing reports of delirium and abnormal behavior in patients with influenza taking neuraminidase inhibitors, including zanamivir (Relenza, Glaxo-SmithKline).
TABLE 73 EUROPEAN MARKET SHARES OF NEURAMINIDASE INHIBITOR MANUFACTURERS,
Kawaoka and a group of researchers from Japan, Vietnam, and Indonesia tested a novel neuraminidase inhibitor R-125489 and its prodrug CS-8958, which had previously shown potent activity against seasonal influenza viruses in laboratory animals.
TABLE 73 U S MARKET SHARES OF NEURAMINIDASE INHIBITOR
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.